The Neonatal Hemorrhagic Risk Assessment in Thrombocytopenia | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
The Neonatal Hemorrhagic Risk Assessment in Thrombocytopenia	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cytopenia, Hemic and Lymphatic Diseases, Hemorrhage, Infant, Newborn, Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, blood platelet disease, hematologic disorder, neonatal thrombocytopenia, thrombocytopenia	Recruiting	Not stated	2024-10-09		NCT04598750

7 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Boston Children's Hospital	238
Harvard Medical School (HMS and HSDM)	37
Karolinska Institutet	493
Karolinska University Hospital	181
National Heart, Lung, and Blood Institute (NHLBI)	791
Region Stockholm	164
The Swedish Society of Medicine	7

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Amsterdam University Medical Centre	Amsterdam	Netherlands	2
Beth Israel Deaconess Medical Center	Boston	United States	462
Boston Children's Hospital	Boston	United States	343
Intermountain Medical Center	Murray	United States	142
Karolinska University Hospital Huddinge campus	Huddinge	Sweden	1
Karolinska University Hospital Solna campus, Astrid Lindgren Children's Hospital	Stockholm	Sweden	1
Leiden University Medical Center	Leiden	Netherlands	54
Utah Valley Hospital	Provo	United States	6